Skip to main content

Table 1 Clinical manifestations of initial presentation of MS patients. n, %

From: The relationship of HLA-G 14-bp insertion/deletion genetic polymorphism to the risk of multiple sclerosis and its clinical phenotypes

 

Number

Percentage

Motor manifestations

 Hemiparesis

15

31.2%

 Monoparesis

2

4.2%

 Paraparesis

5

10.4%

 Quadriparesis

1

2.1%

 Cerebellar ataxia

8

16.7%

 Total

31

64.6%

Visual manifestations

 Optic neuritis

10

20.8%

Sensory manifestations

 Superficial sensory impairment

1

2.1%

 Deep sensory impairment

3

6.2%

 Total

4

8.3%

Brain stem symptoms

 Trigeminal neuralgia

1

2.1%

 Diplopia (INO)

2

4.2%

 Total

3

6.3%

Multiple symptoms at onset

 Optic neuritis with weakness

5

10.4%

 Diplopia (INO) with weakness

1

2.1%

 Total*

6

12.5%

Recovery after first insult

 Complete

14

29.2%

 Incomplete

31

64.6%

 No recovery

3

6.3%

  1. INO internuclear ophthalmoplegia. *12.5% (n=6/48) of patients presented with more than one symptom at onset: five patients presented with optic neuritis and hemiparesis and one patient presented with diplopia due to internuclear ophthalmoplegia and monoparesis